BioMarin building CA plant to support Factor VIII gene therapy candidate – BioPharma-Reporter.com
BioPharma-Reporter.com |
BioMarin building CA plant to support Factor VIII gene therapy candidate
BioPharma-Reporter.com “Our new gene therapy manufacturing facility is expected to be completed by mid-year, enabling us to move the BMN 270 program forward, without constraints on materials needed for the Phase 2b registration enabling study in the third quarter,” CEO … |
